Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain

被引:101
作者
Tassain, V [1 ]
Attal, N [1 ]
Fletcher, D [1 ]
Brasseur, L [1 ]
Dégieux, P [1 ]
Chauvin, M [1 ]
Bouhassira, D [1 ]
机构
[1] Hop Ambroise Pare, Ctr Evaluat & Traitement Douleur, F-92100 Boulogne, France
关键词
morphine; chronic non-cancer pain; cognitive functioning-psychomotor functioning; analgesia;
D O I
10.1016/S0304-3959(03)00047-2
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Morphine is increasingly used in patients with chronic non-cancer pain, but a major concern associated with chronic use relates to possible cognitive side-effects. The aim of this long-term prospective study was to evaluate the cognitive impact of oral sustained release morphine in patients with non-cancer pain. A battery of neuropsychological tests to explore attention, psychomotor speed and memory was administered. The effects of morphine on pain, quality of life, mood, subjective memory impairment and side-effects were also investigated. Evaluations were performed at baseline in patients free from opioids and then after 3, 6 and 12 months. Twenty-eight patients were included: 18 received oral sustained morphine (range 40-140 mg/day), ten patients stopped morphine prematurely because of side-effects or insufficient pain relief and were followed as a control group. There was no impairment of any neuropsychological variable over time in the morphine treated patients in comparison with the control group. Two measures of information processing speed - the Stroop interference score and the digit symbol test were improved at 6 and 12 months and there were significant correlations with the pain relief and improvement of mood. Self-reported memory impairment improved notably in responders to morphine. Morphine induced persisting effects on pain, and to a lesser extent on quality of life and mood. The visual analog scale score for side-effects increased at 12 months and essentially consisted of gastrointestinal disorders. This study demonstrates that 12 months treatment with oral morphine does not disrupt cognitive functioning in patients with chronic non-cancer pain and instead results in moderate improvement of some aspects of cognitive functioning, as a consequence of the pain relief and concomitant improvement of well-being and mood. (C) 2003 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:389 / 400
页数:12
相关论文
共 50 条
  • [21] Sustained release morphine sulfate capsules in patients with pain related to gastrointestinal cancer
    Budai, E
    CLINICAL DRUG INVESTIGATION, 1997, 14 (Suppl 1) : 59 - 61
  • [22] Long-Term Controlled-Release Oxycodone and Pregabalin in the Treatment of Non-Cancer Pain: An Observational Study
    Gatti, A.
    Longo, G.
    Sabato, E.
    Sabato, A. F.
    EUROPEAN NEUROLOGY, 2011, 65 (06) : 317 - 322
  • [23] Comparative efficacy and safety of long-acting oral Opioids for chronic non-cancer pain: A systematic review
    Chou, R
    Clark, E
    Helfand, M
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 26 (05) : 1026 - 1048
  • [24] A LONG-TERM SURVEY OF MORPHINE IN CANCER PAIN PATIENTS
    SCHUG, SA
    ZECH, D
    GROND, S
    JUNG, H
    MEUSER, T
    STOBBE, B
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (05) : 259 - 266
  • [25] Predictors of Long-Term Opioid Effectiveness in Patients With Chronic Non-Cancer Pain Attending Multidisciplinary Pain Treatment Clinics: A Quebec Pain Registry Study
    Kabore, Jean-Luc
    Saidi, Hichem
    Dassieu, Lise
    Choiniere, Manon
    Page, M. Gabrielle
    PAIN PRACTICE, 2020, 20 (06) : 588 - 599
  • [26] Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain
    Allan, L
    Richarz, U
    Simpson, K
    Slappendel, R
    SPINE, 2005, 30 (22) : 2484 - 2490
  • [27] Factors Associated with Suicidal Ideation in Patients with Chronic Non-Cancer Pain
    Racine, Melanie
    Sanchez-Rodriguez, Elisabet
    Galan, Santiago
    Tome-Pires, Catarina
    Sole, Ester
    Jensen, Mark P.
    Nielson, Warren R.
    Miro, Jordi
    Moulin, Dwight E.
    Choiniere, Manon
    PAIN MEDICINE, 2017, 18 (02) : 283 - 293
  • [28] Chronic non-cancer pain and the long-term efficacy and safety of opioids: Some blind men and an elephant?
    Watson, C. Peter N.
    SCANDINAVIAN JOURNAL OF PAIN, 2012, 3 (01) : 5 - 13
  • [29] Opioid misuse in community pharmacy patients with chronic non-cancer pain
    Philip, Camille
    Roy, Sophie
    Eiden, Celine
    Soler, Marion
    Georgin, Francois
    Muller, Agnes
    Picot, Marie-Christine
    Donnadieu-Rigole, Helene
    Peyriere, Helene
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2306 - 2314
  • [30] FACTORS CONTRIBUTING TO THE RESULTS OF LONG-TERM TREATMENT WITH ORAL MORPHINE TABLETS IN PATIENTS WITH CHRONIC NONMALIGNANT PAIN
    SCHULZECK, S
    GLEIM, M
    MAIER, C
    ANAESTHESIST, 1993, 42 (08): : 545 - 556